Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhangzhou Innoessen Bio-technology was a Chinese biotechnology company and a subsidiary of China Technology Development Group Corporation, established in 2006. Based in the Zhangzhou Development Zone, the company operated as a specialized production and manufacturing facility for nutraceutical materials derived from bamboo. Its flagship product, 'Antioxidant of Bamboo Leaves' (AOB), was a natural extract containing bioactive flavonoids like orientin and vitexin, marketed for its antioxidant, anti-aging, and cardiovascular benefits. The company's core technology was developed through a long-term collaboration with researchers at Zhejiang University. In 2007, following a strategic pivot by its parent company toward the solar energy sector, Zhangzhou Innoessen and the broader nutraceutical division were divested.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhangzhou Innoessen.